BJU International | 2008(11) articles

• Bladder Cancer Today
• Dedication
• Epidemiology and genetic susceptibility to bladder cancer
• Bladder cancer, pathological classification and staging
• Genomics: a preview of genomic medicine
• The past, present and future of cystoscopy: the fusion of cystoscopy and novel imaging technology
• Urothelial bladder cancer: biomarkers for detection and screening
• Quality control in transurethral resection of bladder tumours
• Risk-adapted use of intravesical chemotherapy
• Risk-adapted use of intravesical immunotherapy
• The optimal management of T1G3 bladder cancer
• Chemoprevention of bladder cancer
• Outcomes of radical cystectomy
• Cystectomy in women
• Laparoscopic radical cystectomy for muscle-invasive bladder cancer: pathological and oncological outcomes
• Aetiology, diagnosis and management of urothelial tumours of the renal pelvis and ureter
• The orthotopic neobladder
• Continent cutaneous diversion
• Incontinent urinary diversion
• Urinary diversion: evidence-based outcomes assessment and integration into patient decision-making
• Biocompatible materials for bladder substitution
• Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer
• Bladder preservation: optimizing radiotherapy and integrated treatment strategies
• Treatment of metastatic urothelial cancer: opportunities for drug discovery and development